Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recognition of Tumors by the Innate Immune System and Natural Killer Cells
Assaf Marcus, Benjamin G. Gowen, Thornton W. Thompson, et al.
Advances in immunology (2014), pp. 91-128
Open Access | Times Cited: 346

Showing 1-25 of 346 citing articles:

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian, Charles G. Drake, Drew M. Pardoll
Cancer Cell (2015) Vol. 27, Iss. 4, pp. 450-461
Open Access | Times Cited: 3745
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo González, Catharina Hagerling, Zena Werb
Genes & Development (2018) Vol. 32, Iss. 19-20, pp. 1267-1284
Open Access | Times Cited: 1767
Tumor Microenvironment
Borros Arneth
Medicina (2019) Vol. 56, Iss. 1, pp. 15-15
Open Access | Times Cited: 994
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy, Jeff D. Colbert, Kenneth L. Rock
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 698
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu, Jonathan J. Hodgins, Malvika Marathe, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 10, pp. 4654-4668
Open Access | Times Cited: 668
Innate Immune Recognition of Cancer
Seng‐Ryong Woo, Leticia Corrales, Thomas F. Gajewski
Annual Review of Immunology (2015) Vol. 33, Iss. 1, pp. 445-474
Open Access | Times Cited: 520
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
Assaf Marcus, Amy J. Mao, Monisha Lensink-Vasan, et al.
Immunity (2018) Vol. 49, Iss. 4, pp. 754-763.e4
Open Access | Times Cited: 488
Colorectal Cancer Immunotherapy: Options and Strategies
Nor Adzimah Johdi, Nur Fazilah Sukor
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 348
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Xiaolei Li, Changshun Shao, Yufang Shi, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 322
Adrenergic regulation of innate immunity: a review
Angela Scanzano, Marco Cosentino
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 303
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
Wenting Zhang, Qinghua Huang, Weiwei Xiao, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 295
SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling
Victor S. Cortez, Tyler K. Ulland, Luisa Cervantes‐Barragán, et al.
Nature Immunology (2017) Vol. 18, Iss. 9, pp. 995-1003
Open Access | Times Cited: 291
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
Monica Marzagalli, Nancy D. Ebelt, Edwin R. Manuel
Seminars in Cancer Biology (2019) Vol. 59, pp. 236-250
Open Access | Times Cited: 275
Natural killer cell-mediated immunosurveillance of human cancer
Karl‐Johan Malmberg, Mattias Carlsten, Andreas T. Björklund, et al.
Seminars in Immunology (2017) Vol. 31, pp. 20-29
Closed Access | Times Cited: 258
Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights
Sonal Patel, Aftab Alam, Richa Pant, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 234
Immune system and melanoma biology: a balance between immunosurveillance and immune escape
Anna Passarelli, Francesco Mannavola, Luigia Stefania Stucci, et al.
Oncotarget (2017) Vol. 8, Iss. 62, pp. 106132-106142
Open Access | Times Cited: 213
NK cells mediate clearance of CD8 + T cell–resistant tumors in response to STING agonists
Christopher J. Nicolai, Natalie K. Wolf, I-Chang Chang, et al.
Science Immunology (2020) Vol. 5, Iss. 45
Open Access | Times Cited: 211
Natural Killer T Cells in Cancer Immunotherapy
Shiny Nair, Madhav V. Dhodapkar
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 210
Origin and Consequences of Necroinflammation
Maysa Sarhan, W. Land, Wulf Tonnus, et al.
Physiological Reviews (2018) Vol. 98, Iss. 2, pp. 727-780
Open Access | Times Cited: 178
STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma
Jing Hu, Francisco J. Sánchez‐Rivera, Zhenghan Wang, et al.
Nature (2023) Vol. 616, Iss. 7958, pp. 806-813
Open Access | Times Cited: 126
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Kevin Dzobo, Dimakatso Alice Senthebane, Collet Dandara
Cancers (2023) Vol. 15, Iss. 2, pp. 376-376
Open Access | Times Cited: 94
Cancer immune escape: the role of antigen presentation machinery
Anoop Kallingal, Mateusz Olszewski, Natalia Maciejewska, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8131-8141
Open Access | Times Cited: 64
Lessons from patient-derived xenografts for better in vitro modeling of human cancer
Stephen Yiu Chuen Choi, Dong Lin, Peter W. Gout, et al.
Advanced Drug Delivery Reviews (2014) Vol. 79-80, pp. 222-237
Open Access | Times Cited: 167
Targeting NK-cell checkpoints for cancer immunotherapy
Aura Muntasell, María C. Ochoa, Luna Cordeiro, et al.
Current Opinion in Immunology (2017) Vol. 45, pp. 73-81
Closed Access | Times Cited: 164
Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
Kai Li, Shuai Qu, Xi Chen, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 2, pp. 404-404
Open Access | Times Cited: 159
Page 1 - Next Page

Scroll to top